Wirkstoff(e)

• 1-(3-methylbutanoyl)-L-aspartyl-L-threonyl-L-histidyl-L-phenylalanyl-L-prolyl-(L-cystinyl-L-isoleucyl-[(N6-(S)-4-carboxy-4-palmitamidobutanoyl)-L-lysinyl]-L-phenylalanyl-L-glutamyl-L-prolyl-L-arginyl-L-serinyl-L-lysinyl-L-glycinyl-L-cystinyl)-L-lysinamide, disulfide, acetate salt
• 11-(2-Pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)] heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-Decen
• Acetylsalicylic acid
• Fedratinib
• Gegen MicroRNA-451 gerichtetes, chimäres Locked Nucleic Acid (LNA)-Desoxynukleosid Phosphorothioat verknüpftes Oligonukleotid
• Givinostat
• N-(Cyanomethyl)-4-(2-{[4-(Morpholin-4-yl)Phenyl]amino}pyrimidin-4-yl)Benzamid Dihydrochloridsalz
• N-tert-butyl-3-[(5-methyl-2-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}pyrimidin-4-yl)amino] Benzolsulfonamid Hydrochlorid-Monohydrat
• Pegyliertes prolin-interferon alpha-2b
• Plitidepsin
• Pomalidomid
• Recombinant human pentraxin-2
• Ruxolitinib
• Synthetic double-stranded siRNA oligonucleotide directed against TMPRSS6 mRNA and covalently linked to a ligand containing 3 N-acetylgalactosamine residues

Handelsname(n)

• BESREMI
• HYDREA
• INREBIC
• JAKAFI
• JAKAVI
• VONJO